查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球放射性药物临床前 CRO 市场：成长、未来前景、竞争分析，2024-2032 年
市场调查报告书
商品编码
1402951

全球放射性药物临床前 CRO 市场：成长、未来前景、竞争分析，2024-2032 年

Radiopharmaceutical Preclinical CRO Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032
出版日期: | 出版商: Acute Market Reports | 英文 115 Pages | 商品交期: 最快1-2个工作天内

价格

放射性药物临床前 CRO（合约研究组织）市场是一个充满活力的领域，对于推进放射性药物领域的临床前研究至关重要。预计，由于PET 示踪剂研究的进步、肿瘤学和神经病学研究需求的增长以及CRO 之间的战略联盟，放射性药物临床前CRO 市场在2024 年至2032 年的预测期内将以8.5% 的复合年增长率增长。治疗性放射性药物开发的挑战凸显了无缝转化研究的重要性。按放射性药物类型和治疗领域进行细分可以提供对市场动态的细緻入微的了解，突显向治疗应用的转变以及神经学研究日益增长的重要性。地理划分突显了全球趋势以及亚太地区在塑造临床前放射性药物研究的未来方面的关键作用。

PET示踪研究进展

PET（正子断层扫描）追踪剂研究的进展极大地激活了放射性药物临床前 CRO 市场。作为这一点的证据，Covance和 Charles River Laboratories 等领先的 CRO 正在积极致力于开发用于各种临床前研究的新型 PET 示踪剂。PET 追踪剂提高的敏感度和准确性将使临床前研究中的影像和分析更加精确，有助于更深入地了解疾病机制和治疗反应。

对肿瘤学研究的需求不断增长

肿瘤学研究需求的不断增长是放射性药物临床前 CRO 市场的主要驱动因素。Jubilant Biosys 和 Selcia 等 CRO 也有证据显示肿瘤学的临床前研究正在迅速增加。肿瘤治疗领域不仅将在 2024 年产生可观的收入，而且在 2024-2032 年的预测期内将呈现出最高的复合年增长率。这证实了 CRO 在支持癌症研究的进步以及为诊断和治疗目的创新放射性药物的研发做出贡献方面的重要作用。

人们对神经学研究的兴趣日益浓厚

对神经学研究日益浓厚的兴趣已成为放射性药物临床前 CRO 市场的另一个驱动因素。实证洞察表明，Pharmaron和WuXi AppTec等 CRO 正在积极从事神经病学的临床前研究。由于影像技术的进步和对神经退化性疾病的更好理解，神经病学治疗领域在预测期内将表现出强劲的收入和较高的预期复合年增长率。这凸显了CRO在支持神经科学研究方面的重要作用，并为神经系统疾病诊断和治疗的突破铺平了道路。

开发治疗性放射性药物的挑战

儘管势头良好，但治疗性放射性药物开发的挑战仍然是一个重大障碍。有证据表明，将临床前研究结果转化为临床上可行的治疗性放射性药物时偶尔会遇到障碍。Eurofins DiscoverX 和 Nuvisan 等 CRO 正在积极应对这些挑战，强调需要从临床前开发到临床开发无缝过渡。这项障碍凸显了合作努力和强大的转化研究框架的重要性，以克服障碍并促进临床前验证的放射性药物转化为临床。

按放射性药物类型进行市场分析：PET示踪剂占据市场主导地位

按放射性药物类型进行的市场细分揭示了 PET 示踪剂、SPECT（单光子发射电脑断层扫描）示踪剂和治疗放射性药物的动态趋势。到 2024 年，PET 示踪剂将主导市场，产生最高的收入，并对整体市场份额做出重大贡献。然而，在 2024 年至 2032 年的预测期内，治疗性放射性药物的预期复合年增长率最高。这种细分支撑了放射性药物临床前研究的发展，并显着转向治疗应用。

按治疗领域分析：癌症领域占市场主导地位

按治疗领域的市场细分凸显了肿瘤学、心臟病学、神经学和其他领域在临床前研究中的主导地位。由于癌症相关研究日益受到关注，到 2024 年，肿瘤学将拥有最高的销售额。同时，神经病学在 2024-2032 年预测期内的预期复合年增长率最高，反映出人们对理解和解决神经系统疾病的日益关注。这种细分提供了对放射性药物在多个治疗领域的临床前测试中的多种用途的深入了解。

北美仍处于世界领先地位

放射性药物临床前 CRO 市场的地理细分揭示了全球趋势和区域差异。到 2024 年，北美地区将在收入和市场份额方面均处于领先地位，其中 Covance 和 Charles River Laboratories 等 CRO 将发挥关键作用。然而，由于新兴经济体更注重研发以及与全球製药公司的合作增加等因素，预计亚太地区在预测期内将呈现最高的复合年增长率。这项变化凸显了市场的全球性以及製定区域策略以适应多样化研究环境的必要性。

预测期内市场竞争将加剧

竞争格局的特征是策略联盟和整体市场前景。截至2024年，Covance、Charles River Laboratories、Pharmaron等CRO在市场上占据主导地位，反映了他们的综合能力和对临床前研究的重大贡献。策略包括与製药公司成立合资企业、扩大服务范围以及投资尖端技术。从2024年到2032年，这些CRO预计将继续其策略性举措，适应新的市场动态，并为全球放射性药物研究的进步做出贡献。

本报告回答的关键问题

影响放射性药物临床前 CRO 市场成长的关键微观和宏观环境因素有哪些？

现在和预测期内，就产品领域和地区而言，主要投资领域为何？

2032 年之前的预估与市场预测

在预测期间内，哪个细分市场的复合年增长率最快？

哪个细分市场拥有较大的市场份额，为什么？

低收入和中等收入国家是否投资放射性药物临床前 CRO 市场？

放射性药物临床前 CRO 市场最大的区域市场是哪一个？

亚太、拉丁美洲、中东/非洲等新兴市场的市场趋势与动态如何？

推动放射性药物临床前 CRO 市场成长的主要趋势是什么？

主要竞争对手有哪些，以及他们提高在全球放射性药物临床前 CRO 市场占有率的策略是什么？

目录

第一章 前言

  • 报告内容
  • 市场细分
  • 调查方法

第二章执行摘要

第三章放射性药物临床前CRO市场：竞争分析

  • 主要供应商的市场地位
  • 供应商采取的策略
  • 主要产业战略
  • 等级分析：2023 年与 2031 年

第四章放射性药物临床前CRO市场：宏观分析与市场动态

  • 介绍
  • 2021-2031年全球放射性药物临床前CRO市场价值
  • 市场动态
    • 市场驱动力
    • 市场制约因素
    • 主要问题
    • 主要机会
  • 促进因素和抑制因素的影响分析
  • 跷跷板分析
  • 波特的五力模型
    • 供应商权力
    • 买方的权力
    • 替代品的威胁
    • 新进入者的威胁
    • 竞争对手之间的竞争
  • PESTEL 分析
    • 政局
    • 金融情况
    • 技术状况
    • 法律状况
    • 社会局势

第五章放射性药物临床前 CRO 市场：依服务类型，2022-2032 年

  • 市场概况
  • 成长/利润分析：2023 年与 2031 年
  • 市场细分
    • 安全评价
    • 生物分析测试
    • 剂量配方
    • 监管支持

第六章 放射性药物临床前 CRO 市场：依最终用途产业划分，2022-2032 年

  • 市场概况
  • 成长/利润分析：2023 年与 2031 年
  • 市场细分
    • 製药公司
    • 生物技术公司
    • 学术研究机构
    • 政府机构

第 7 章 放射性药物临床前 CRO 市场：依放射性药物类型，2022-2032 年

  • 市场概况
  • 成长/利润分析：2023 年与 2031 年
  • 市场细分
    • PET示踪剂
    • SPECT示踪剂
    • 治疗性放射性药物

第八章放射性药物临床前 CRO 市场：依治疗领域，2022-2032 年

  • 市场概况
  • 成长/利润分析：2023 年与 2031 年
  • 市场细分
    • 肿瘤学
    • 心臟病学
    • 神经病学
    • 其他

第9章放射性药物临床前CRO市场：依组织规模，2022-2032年

  • 市场概况
  • 成长/利润分析：2023 年与 2031 年
  • 市场细分
    • 中小型企业 (SME)
    • 大製药公司

第十章 北美放射性药物临床前 CRO 市场，2022-2032

  • 市场概况
  • 放射性药物临床前 CRO 市场：按服务类型划分，2022-2032 年
  • 放射性药物临床前 CRO 市场：依最终用途产业划分，2022-2032 年
  • 放射性药物临床前 CRO 市场：以放射性药物类型划分，2022-2032 年
  • 放射性药物临床前 CRO 市场：依治疗领域，2022-2032 年
  • 放射性药物临床前 CRO 市场：依组织规模划分，2022-2032 年
  • 放射性药物临床前 CRO 市场：按地区划分，2022-2032 年
    • 北美
      • 美国
      • 加拿大
      • 北美其他地区

第十一章 英国/欧盟放射性药物临床前 CRO 市场，2022-2032

  • 市场概况
  • 放射性药物临床前 CRO 市场：按服务类型划分，2022-2032 年
  • 放射性药物临床前 CRO 市场：依最终用途产业划分，2022-2032 年
  • 放射性药物临床前 CRO 市场：以放射性药物类型划分，2022-2032 年
  • 放射性药物临床前 CRO 市场：依治疗领域，2022-2032 年
  • 放射性药物临床前 CRO 市场：依组织规模划分，2022-2032 年
  • 放射性药物临床前 CRO 市场：按地区划分，2022-2032 年
    • 英国/欧盟
      • 英国
      • 德国
      • 西班牙
      • 义大利
      • 法国
      • 其他英国/欧盟

第十二章亚太放射性药物临床前CRO市场，2022-2032

  • 市场概况
  • 放射性药物临床前 CRO 市场：按服务类型划分，2022-2032 年
  • 放射性药物临床前 CRO 市场：依最终用途产业划分，2022-2032 年
  • 放射性药物临床前 CRO 市场：以放射性药物类型划分，2022-2032 年
  • 放射性药物临床前 CRO 市场：依治疗领域，2022-2032 年
  • 放射性药物临床前 CRO 市场：依组织规模划分，2022-2032 年
  • 放射性药物临床前 CRO 市场：按地区划分，2022-2032 年
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 亚太其他地区

第十三章拉丁美洲放射性药物临床前 CRO 市场，2022-2032

  • 市场概况
  • 放射性药物临床前 CRO 市场：按服务类型划分，2022-2032 年
  • 放射性药物临床前 CRO 市场：依最终用途产业划分，2022-2032 年
  • 放射性药物临床前 CRO 市场：以放射性药物类型划分，2022-2032 年
  • 放射性药物临床前 CRO 市场：依治疗领域，2022-2032 年
  • 放射性药物临床前 CRO 市场：依组织规模划分，2022-2032 年
  • 放射性药物临床前 CRO 市场：按地区划分，2022-2032 年
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲

第14章中东与非洲放射性药物临床前CRO市场，2022-2032

  • 市场概况
  • 放射性药物临床前 CRO 市场：按服务类型划分，2022-2032 年
  • 放射性药物临床前 CRO 市场：依最终用途产业划分，2022-2032 年
  • 放射性药物临床前 CRO 市场：以放射性药物类型划分，2022-2032 年
  • 放射性药物临床前 CRO 市场：依治疗领域，2022-2032 年
  • 放射性药物临床前 CRO 市场：依组织规模划分，2022-2032 年
  • 放射性药物临床前 CRO 市场：按地区划分，2022-2032 年
    • 中东/非洲
      • 海湾合作委员会
      • 非洲
      • 其他中东/非洲

第十五章公司简介

  • Charles River Laboratories International Inc.
  • Pharmaron Beijing Co. Ltd.
  • Bioscan Inc.
  • Invicro（Konica Minolta）
  • PerkinElmer Inc.
  • Siemens Healthineers
  • IBA Radiopharma Solutions
  • Covance Inc.（Labcorp Drug Development）
  • NorthStar Medical Radioisotopes LLC
  • PAREXEL International Corporation
  • Eckert & Ziegler
  • Jubilant Radiopharma
  • Cardinal Health Inc.
  • Curium Pharma
  • ImaginAb Inc.
  • 其他主要公司
Product Code: 140035-11-23

The radiopharmaceutical preclinical CRO (Contract Research Organization) market is a dynamic sector, integral to advancing preclinical research in the field of radiopharmaceuticals. The radiopharmaceutical preclinical CRO market is expected to grow at a CAGR of 8.5% during the forecast period of 2024 to 2032, driven by advancements in PET tracers research, the growing demand for oncology and neurology studies, and strategic collaborations among CROs. Challenges in therapeutic radiopharmaceutical development highlight the importance of seamless translational research. The segmentation by radiopharmaceutical type and therapeutic area provides a nuanced understanding of market dynamics, emphasizing the shift towards therapeutic applications and the rising significance of neurology research. The geographic segmentation underscores global trends and the pivotal role of regions like Asia-Pacific in shaping the future of preclinical radiopharmaceutical research.

Advancements in PET Tracers Research

The radiopharmaceutical preclinical CRO market experiences a significant boost from the ongoing advancements in PET (Positron Emission Tomography) tracers research. Evidence suggests that leading CROs, such as Covance and Charles River Laboratories, have actively contributed to the development of novel PET tracers for various preclinical studies. The increased sensitivity and precision offered by PET tracers enable more accurate imaging and analysis in preclinical trials, facilitating a deeper understanding of disease mechanisms and therapeutic responses.

Growing Demand for Oncology Research

The growing demand for oncology research acts as a major driver for the radiopharmaceutical preclinical CRO market. Evidential data indicates that CROs, including Jubilant Biosys and Selcia, have witnessed a surge in preclinical studies focused on oncology. The oncology therapeutic area not only commands substantial revenue in 2024 but also exhibits the highest expected CAGR during the forecast period from 2024 to 2032. This driver underscores the pivotal role of CROs in supporting advancements in cancer research, contributing to the development of innovative radiopharmaceuticals for diagnostic and therapeutic purposes.

Rising Interest in Neurology Studies

The rising interest in neurology studies emerges as another driver for the radiopharmaceutical preclinical CRO market. Evidence-based insights reveal that CROs, such as Pharmaron and WuXi AppTec, are actively engaged in preclinical research focusing on neurology. With advancements in imaging techniques and a growing understanding of neurodegenerative disorders, the neurology therapeutic area exhibits both substantial revenue and a high expected CAGR during the forecast period. This driver highlights the crucial role of CROs in supporting neuroscience research, paving the way for potential breakthroughs in the diagnosis and treatment of neurological conditions.

Challenges in Therapeutic Radiopharmaceutical Development

Despite the positive momentum, challenges in therapeutic radiopharmaceutical development pose a notable restraint. Evidence suggests occasional hurdles in the translation of preclinical findings to clinically viable therapeutic radiopharmaceuticals. CROs, including Eurofins DiscoverX and Nuvisan, actively address these challenges, emphasizing the need for seamless transitions from preclinical to clinical development. This restraint underscores the importance of collaborative efforts and a robust translational research framework to overcome barriers and expedite the clinical translation of preclinically validated radiopharmaceuticals.

Market Analysis by Radiopharmaceutical Type: PET Tracers Dominate the Market

Market segmentation by radiopharmaceutical type reveals dynamic trends in PET tracers, SPECT (Single Photon Emission Computed Tomography) tracers, and therapeutic radiopharmaceuticals. In 2024, PET tracers dominated the market, with the highest revenue and a significant contribution to the overall market share. However, the highest expected CAGR during the forecast period from 2024 to 2032 is in therapeutic radiopharmaceuticals. This segmentation underscores the evolving landscape of radiopharmaceutical preclinical research, with a notable shift toward therapeutic applications.

Market Analysis by Therapeutic Area: Oncology Segment Dominates the Market

The market segmentation by therapeutic area highlights the prominence of oncology, cardiology, neurology, and other areas in preclinical research. In 2024, oncology commands the highest revenue, driven by the increasing focus on cancer-related studies. Simultaneously, neurology emerges with the highest expected CAGR during the forecast period from 2024 to 2032, reflecting a growing emphasis on understanding and addressing neurological disorders. This segmentation provides insights into the diverse applications of radiopharmaceuticals in preclinical studies across multiple therapeutic areas.

North America Remains the Global Leader

The geographic segmentation of the radiopharmaceutical preclinical CRO market unveils global trends and regional variances. In 2024, North America led in terms of both revenue and market share, with CROs like Covance and Charles River Laboratories playing a significant role. However, Asia-Pacific is expected to exhibit the highest CAGR during the forecast period, driven by factors such as a growing focus on research and development in emerging economies and increasing collaborations with global pharmaceutical companies. This shift highlights the global nature of the market and the need for region-specific strategies to cater to diverse research landscapes.

Market Competition to Intensify during the Forecast Period

The competitive landscape of the radiopharmaceutical preclinical CRO market is characterized by strategic collaborations and a holistic market outlook. In 2024, CROs such as Covance, Charles River Laboratories, and Pharmaron dominated the market, reflecting their comprehensive capabilities and significant contributions to preclinical research. Strategies encompass collaborative ventures with pharmaceutical companies, expansion of service offerings, and investments in cutting-edge technologies. Looking ahead to the period from 2024 to 2032, these CROs are expected to continue their strategic initiatives, adapting to emerging market dynamics and contributing to the advancement of radiopharmaceutical research on a global scale.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofRadiopharmaceutical Preclinical CRO market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Radiopharmaceutical Preclinical CRO market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Service Type

    • Safety Assessment
    • Bioanalytical Testing
    • Dose Formulation
    • Regulatory Affairs Support

End-Use Industry

    • Pharmaceutical Companies
    • Biotechnology Firms
    • Academic Research Institutions
    • Government Organizations

Radiopharmaceutical Type

    • PET Tracers
    • SPECT Tracers
    • Therapeutic Radiopharmaceuticals

Therapeutic Area

    • Oncology
    • Cardiology
    • Neurology
    • Others

Organization Size

    • Small and Medium Enterprises (SMEs)
    • Large Pharmaceutical Corporations

Region Segment (2022-2032; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Radiopharmaceutical Preclinical CRO market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2032.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Radiopharmaceutical Preclinical CRO market?

Which is the largest regional market for Radiopharmaceutical Preclinical CRO market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Radiopharmaceutical Preclinical CRO market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Radiopharmaceutical Preclinical CRO market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Radiopharmaceutical Preclinical CRO Market
  • 2.2. Global Radiopharmaceutical Preclinical CRO Market, By Service Type, 2023 (US$ Million)
  • 2.3. Global Radiopharmaceutical Preclinical CRO Market, By End-Use Industry, 2023 (US$ Million)
  • 2.4. Global Radiopharmaceutical Preclinical CRO Market, By Radiopharmaceutical Type, 2023 (US$ Million)
  • 2.5. Global Radiopharmaceutical Preclinical CRO Market, By Therapeutic Area, 2023 (US$ Million)
  • 2.6. Global Radiopharmaceutical Preclinical CRO Market, By Organization Size, 2023 (US$ Million)
  • 2.7. Global Radiopharmaceutical Preclinical CRO Market, By Geography, 2023 (US$ Million)
  • 2.8. Attractive Investment Proposition by Geography, 2023

3. Radiopharmaceutical Preclinical CRO Market: Competitive Analysis

  • 3.1. Market Positioning of Key Radiopharmaceutical Preclinical CRO Market Vendors
  • 3.2. Strategies Adopted by Radiopharmaceutical Preclinical CRO Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2023 Versus 2031

4. Radiopharmaceutical Preclinical CRO Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Radiopharmaceutical Preclinical CRO Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2023 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Safety Assessment
    • 5.3.2. Bioanalytical Testing
    • 5.3.3. Dose Formulation
    • 5.3.4. Regulatory Affairs Support

6. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2023 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Pharmaceutical Companies
    • 6.3.2. Biotechnology Firms
    • 6.3.3. Academic Research Institutions
    • 6.3.4. Government Organizations

7. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2023 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. PET Tracers
    • 7.3.2. SPECT Tracers
    • 7.3.3. Therapeutic Radiopharmaceuticals

8. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)

  • 8.1. Market Overview
  • 8.2. Growth & Revenue Analysis: 2023 Versus 2031
  • 8.3. Market Segmentation
    • 8.3.1. Oncology
    • 8.3.2. Cardiology
    • 8.3.3. Neurology
    • 8.3.4. Others

9. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)

  • 9.1. Market Overview
  • 9.2. Growth & Revenue Analysis: 2023 Versus 2031
  • 9.3. Market Segmentation
    • 9.3.1. Small and Medium Enterprises (SMEs)
    • 9.3.2. Large Pharmaceutical Corporations

10. North America Radiopharmaceutical Preclinical CRO Market, 2022-2032, USD (Million)

  • 10.1. Market Overview
  • 10.2. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
  • 10.3. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
  • 10.4. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • 10.5. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
  • 10.6. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
  • 10.7.Radiopharmaceutical Preclinical CRO Market: By Region, 2022-2032, USD (Million)
    • 10.7.1.North America
      • 10.7.1.1. U.S.
        • 10.7.1.1.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 10.7.1.1.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 10.7.1.1.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 10.7.1.1.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 10.7.1.1.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 10.7.1.2. Canada
        • 10.7.1.2.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 10.7.1.2.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 10.7.1.2.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 10.7.1.2.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 10.7.1.2.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 10.7.1.3. Rest of North America
        • 10.7.1.3.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 10.7.1.3.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 10.7.1.3.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 10.7.1.3.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 10.7.1.3.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)

11. UK and European Union Radiopharmaceutical Preclinical CRO Market, 2022-2032, USD (Million)

  • 11.1. Market Overview
  • 11.2. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
  • 11.3. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
  • 11.4. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • 11.5. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
  • 11.6. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
  • 11.7.Radiopharmaceutical Preclinical CRO Market: By Region, 2022-2032, USD (Million)
    • 11.7.1.UK and European Union
      • 11.7.1.1. UK
        • 11.7.1.1.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 11.7.1.1.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 11.7.1.1.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 11.7.1.1.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 11.7.1.1.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 11.7.1.2. Germany
        • 11.7.1.2.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 11.7.1.2.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 11.7.1.2.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 11.7.1.2.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 11.7.1.2.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 11.7.1.3. Spain
        • 11.7.1.3.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 11.7.1.3.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 11.7.1.3.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 11.7.1.3.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 11.7.1.3.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 11.7.1.4. Italy
        • 11.7.1.4.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 11.7.1.4.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 11.7.1.4.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 11.7.1.4.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 11.7.1.4.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 11.7.1.5. France
        • 11.7.1.5.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 11.7.1.5.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 11.7.1.5.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 11.7.1.5.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 11.7.1.5.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 11.7.1.6. Rest of Europe
        • 11.7.1.6.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 11.7.1.6.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 11.7.1.6.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 11.7.1.6.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 11.7.1.6.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)

12. Asia Pacific Radiopharmaceutical Preclinical CRO Market, 2022-2032, USD (Million)

  • 12.1. Market Overview
  • 12.2. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
  • 12.3. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
  • 12.4. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • 12.5. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
  • 12.6. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
  • 12.7.Radiopharmaceutical Preclinical CRO Market: By Region, 2022-2032, USD (Million)
    • 12.7.1.Asia Pacific
      • 12.7.1.1. China
        • 12.7.1.1.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 12.7.1.1.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 12.7.1.1.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 12.7.1.1.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 12.7.1.1.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 12.7.1.2. Japan
        • 12.7.1.2.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 12.7.1.2.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 12.7.1.2.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 12.7.1.2.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 12.7.1.2.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 12.7.1.3. India
        • 12.7.1.3.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 12.7.1.3.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 12.7.1.3.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 12.7.1.3.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 12.7.1.3.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 12.7.1.4. Australia
        • 12.7.1.4.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 12.7.1.4.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 12.7.1.4.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 12.7.1.4.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 12.7.1.4.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 12.7.1.5. South Korea
        • 12.7.1.5.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 12.7.1.5.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 12.7.1.5.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 12.7.1.5.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 12.7.1.5.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 12.7.1.6. Rest of Asia Pacific
        • 12.7.1.6.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 12.7.1.6.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 12.7.1.6.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 12.7.1.6.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 12.7.1.6.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)

13. Latin America Radiopharmaceutical Preclinical CRO Market, 2022-2032, USD (Million)

  • 13.1. Market Overview
  • 13.2. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
  • 13.3. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
  • 13.4. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • 13.5. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
  • 13.6. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
  • 13.7.Radiopharmaceutical Preclinical CRO Market: By Region, 2022-2032, USD (Million)
    • 13.7.1.Latin America
      • 13.7.1.1. Brazil
        • 13.7.1.1.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 13.7.1.1.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 13.7.1.1.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 13.7.1.1.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 13.7.1.1.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 13.7.1.2. Mexico
        • 13.7.1.2.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 13.7.1.2.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 13.7.1.2.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 13.7.1.2.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 13.7.1.2.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 13.7.1.3. Rest of Latin America
        • 13.7.1.3.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 13.7.1.3.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 13.7.1.3.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 13.7.1.3.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 13.7.1.3.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)

14. Middle East and Africa Radiopharmaceutical Preclinical CRO Market, 2022-2032, USD (Million)

  • 14.1. Market Overview
  • 14.2. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
  • 14.3. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
  • 14.4. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • 14.5. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
  • 14.6. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
  • 14.7.Radiopharmaceutical Preclinical CRO Market: By Region, 2022-2032, USD (Million)
    • 14.7.1.Middle East and Africa
      • 14.7.1.1. GCC
        • 14.7.1.1.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 14.7.1.1.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 14.7.1.1.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 14.7.1.1.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 14.7.1.1.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 14.7.1.2. Africa
        • 14.7.1.2.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 14.7.1.2.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 14.7.1.2.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 14.7.1.2.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 14.7.1.2.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 14.7.1.3. Rest of Middle East and Africa
        • 14.7.1.3.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 14.7.1.3.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 14.7.1.3.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 14.7.1.3.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 14.7.1.3.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)

15. Company Profile

  • 15.1. Charles River Laboratories International, Inc.
    • 15.1.1. Company Overview
    • 15.1.2. Financial Performance
    • 15.1.3. Product Portfolio
    • 15.1.4. Strategic Initiatives
  • 15.2. Pharmaron Beijing Co., Ltd.
    • 15.2.1. Company Overview
    • 15.2.2. Financial Performance
    • 15.2.3. Product Portfolio
    • 15.2.4. Strategic Initiatives
  • 15.3. Bioscan, Inc.
    • 15.3.1. Company Overview
    • 15.3.2. Financial Performance
    • 15.3.3. Product Portfolio
    • 15.3.4. Strategic Initiatives
  • 15.4. Invicro (Konica Minolta)
    • 15.4.1. Company Overview
    • 15.4.2. Financial Performance
    • 15.4.3. Product Portfolio
    • 15.4.4. Strategic Initiatives
  • 15.5. PerkinElmer, Inc.
    • 15.5.1. Company Overview
    • 15.5.2. Financial Performance
    • 15.5.3. Product Portfolio
    • 15.5.4. Strategic Initiatives
  • 15.6. Siemens Healthineers
    • 15.6.1. Company Overview
    • 15.6.2. Financial Performance
    • 15.6.3. Product Portfolio
    • 15.6.4. Strategic Initiatives
  • 15.7. IBA Radiopharma Solutions
    • 15.7.1. Company Overview
    • 15.7.2. Financial Performance
    • 15.7.3. Product Portfolio
    • 15.7.4. Strategic Initiatives
  • 15.8. Covance, Inc. (Labcorp Drug Development)
    • 15.8.1. Company Overview
    • 15.8.2. Financial Performance
    • 15.8.3. Product Portfolio
    • 15.8.4. Strategic Initiatives
  • 15.9. NorthStar Medical Radioisotopes, LLC
    • 15.9.1. Company Overview
    • 15.9.2. Financial Performance
    • 15.9.3. Product Portfolio
    • 15.9.4. Strategic Initiatives
  • 15.10. PAREXEL International Corporation
    • 15.10.1. Company Overview
    • 15.10.2. Financial Performance
    • 15.10.3. Product Portfolio
    • 15.10.4. Strategic Initiatives
  • 15.11. Eckert & Ziegler
    • 15.11.1. Company Overview
    • 15.11.2. Financial Performance
    • 15.11.3. Product Portfolio
    • 15.11.4. Strategic Initiatives
  • 15.12. Jubilant Radiopharma
    • 15.12.1. Company Overview
    • 15.12.2. Financial Performance
    • 15.12.3. Product Portfolio
    • 15.12.4. Strategic Initiatives
  • 15.13. Cardinal Health, Inc.
    • 15.13.1. Company Overview
    • 15.13.2. Financial Performance
    • 15.13.3. Product Portfolio
    • 15.13.4. Strategic Initiatives
  • 15.14. Curium Pharma
    • 15.14.1. Company Overview
    • 15.14.2. Financial Performance
    • 15.14.3. Product Portfolio
    • 15.14.4. Strategic Initiatives
  • 15.15. ImaginAb, Inc.
    • 15.15.1. Company Overview
    • 15.15.2. Financial Performance
    • 15.15.3. Product Portfolio
    • 15.15.4. Strategic Initiatives
  • 15.16. Other Notable Players
    • 15.16.1. Company Overview
    • 15.16.2. Financial Performance
    • 15.16.3. Product Portfolio
    • 15.16.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 2 Global Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 3 Global Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 4 Global Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 5 Global Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 6 North America Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 7 North America Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 8 North America Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 9 North America Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 10 North America Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 11 U.S. Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 12 U.S. Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 13 U.S. Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 14 U.S. Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 15 U.S. Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 16 Canada Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 17 Canada Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 18 Canada Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 19 Canada Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 20 Canada Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 21 Rest of North America Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 22 Rest of North America Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 23 Rest of North America Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 24 Rest of North America Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 25 Rest of North America Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 26 UK and European Union Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 27 UK and European Union Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 28 UK and European Union Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 29 UK and European Union Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 30 UK and European Union Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 31 UK Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 32 UK Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 33 UK Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 34 UK Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 35 UK Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 36 Germany Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 37 Germany Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 38 Germany Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 39 Germany Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 40 Germany Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 41 Spain Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 42 Spain Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 43 Spain Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 44 Spain Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 45 Spain Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 46 Italy Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 47 Italy Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 48 Italy Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 49 Italy Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 50 Italy Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 51 France Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 52 France Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 53 France Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 54 France Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 55 France Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 56 Rest of Europe Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 57 Rest of Europe Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 58 Rest of Europe Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 59 Rest of Europe Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 60 Rest of Europe Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 61 Asia Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 62 Asia Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 63 Asia Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 64 Asia Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 65 Asia Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 66 China Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 67 China Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 68 China Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 69 China Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 70 China Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 71 Japan Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 72 Japan Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 73 Japan Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 74 Japan Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 75 Japan Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 76 India Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 77 India Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 78 India Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 79 India Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 80 India Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 81 Australia Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 82 Australia Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 83 Australia Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 84 Australia Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 85 Australia Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 86 South Korea Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 87 South Korea Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 88 South Korea Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 89 South Korea Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 90 South Korea Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 91 Latin America Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 92 Latin America Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 93 Latin America Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 94 Latin America Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 95 Latin America Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 96 Brazil Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 97 Brazil Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 98 Brazil Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 99 Brazil Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 100 Brazil Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 101 Mexico Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 102 Mexico Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 103 Mexico Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 104 Mexico Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 105 Mexico Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 106 Rest of Latin America Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 107 Rest of Latin America Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 108 Rest of Latin America Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 109 Rest of Latin America Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 110 Rest of Latin America Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 111 Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 112 Middle East and Africa Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 113 Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 114 Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 115 Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 116 GCC Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 117 GCC Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 118 GCC Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 119 GCC Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 120 GCC Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 121 Africa Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 122 Africa Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 123 Africa Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 124 Africa Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 125 Africa Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 126 Rest of Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 127 Rest of Middle East and Africa Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 128 Rest of Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 129 Rest of Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 130 Rest of Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)

List of Figures

  • FIG. 1 Global Radiopharmaceutical Preclinical CRO Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Radiopharmaceutical Preclinical CRO Market: Quality Assurance
  • FIG. 5 Global Radiopharmaceutical Preclinical CRO Market, By Service Type, 2023
  • FIG. 6 Global Radiopharmaceutical Preclinical CRO Market, By End-Use Industry, 2023
  • FIG. 7 Global Radiopharmaceutical Preclinical CRO Market, By Radiopharmaceutical Type, 2023
  • FIG. 8 Global Radiopharmaceutical Preclinical CRO Market, By Therapeutic Area, 2023
  • FIG. 9 Global Radiopharmaceutical Preclinical CRO Market, By Organization Size, 2023
  • FIG. 10 Global Radiopharmaceutical Preclinical CRO Market, By Geography, 2023
  • FIG. 11 Market Geographical Opportunity Matrix - Global Radiopharmaceutical Preclinical CRO Market, 2023

FIG. 12Market Positioning of Key Radiopharmaceutical Preclinical CRO Market Players, 2023

FIG. 13Global Radiopharmaceutical Preclinical CRO Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2031

  • FIG. 14 Global Radiopharmaceutical Preclinical CRO Market, By Service Type, 2023 Vs 2032, %
  • FIG. 15 Global Radiopharmaceutical Preclinical CRO Market, By End-Use Industry, 2023 Vs 2032, %
  • FIG. 16 Global Radiopharmaceutical Preclinical CRO Market, By Radiopharmaceutical Type, 2023 Vs 2032, %
  • FIG. 17 Global Radiopharmaceutical Preclinical CRO Market, By Therapeutic Area, 2023 Vs 2032, %
  • FIG. 18 Global Radiopharmaceutical Preclinical CRO Market, By Organization Size, 2023 Vs 2032, %
  • FIG. 19 U.S. Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 20 Canada Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 21 Rest of North America Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 22 UK Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 23 Germany Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 24 Spain Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 25 Italy Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 26 France Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 27 Rest of Europe Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 28 China Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 29 Japan Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 30 India Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 31 Australia Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 32 South Korea Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 33 Rest of Asia Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 34 Brazil Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 35 Mexico Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 36 Rest of Latin America Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 37 GCC Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 38 Africa Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 39 Rest of Middle East and Africa Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032